
Plasma-Engineered Biomaterials for Precision Oncology


PlasmOnCo's biomaterials are designed for precise interaction with the cellular microenvironment, enabling unprecedented control over biological responses at the site of disease.
Modulating Biological Responses at Cell Level
From fundamental physics to translational oncology, our therapeutic platforms bridge laboratory discovery with human impact, accelerating the development of advanced cancer therapeutics.
Social Impact
Transforming Cancer Care
Our solution has the potential to deliver more effective cancer care while reducing the burden on patients and healthcare systems. Fewer recurrences and secondary surgeries could mean lower healthcare costs and improved long-term outcomes. By enabling more conservative treatments, we aim to increase survival chances and to help patients preserve function, quality of life, and hope beyond cancer.
Localized Action
Personalized Treatment
Selective Effect
Enhance therapeutic concentration directly at the tumor site, maximizing efficacy and improving local tumor control.
Versatile platform adaptable to each patient's requirements, precisely conforming to the morphology of the resected cavity or the affected site. Its flexibility allows patient-specific treatment across multiple cancer types.
Selective elimination of cancer cells while preserving healthy tissues, minimizing local and systemic toxicity through targeted therapeutic action, while offering potential synergies with existing cancer treatments.
We invite researchers, clinicians, investors & pharmaceutical partners to explore our platform and collaborate on the next generation of oncology solutions.
